Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations

Scientific Reports

Volumn 5, Issue , 2015, Pages 8250-

  Zhu, Jinhong ^a,b,c   Wang, Mengyun ^a,b   Zhu, Meiling ^d   He, Jin ^e   Wang, Jiu Cun ^f,g   Jin, Li ^f,g   Wang, Xiao Feng ^f,g   Xiang, Jia Qing ^a   Wei, Qingyi ^a,h  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

^d XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^f FUDAN UNIVERSITY   (China)

^g Fudan Taizhou Institute of Health Sciences   (China)

^h DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; TARGET OF RAPAMYCIN KINASE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CHINA; EPISTASIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; ODDS RATIO; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; EPISTASIS, GENETIC; ESOPHAGEAL NEOPLASMS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TOR SERINE-THREONINE KINASES;

EID: 84923166615     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08250     Document Type: Article

References (39)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90, doi:10.3322/caac.20107 (2011).
2. Tran, G. D. et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 113, 456-463, doi:10.1002/ijc.20616 (2005).
3. Hiyama, T., Yoshihara, M., Tanaka, S. & Chayama, K. Genetic polymorphisms and esophageal cancer risk. Int J Cancer 121, 1643-1658, doi:10.1002/ijc.23044 (2007).
4. Xing, D., Tan, W. & Lin, D. Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). Oncol Rep 10, 1615-1623 (2003).
5. Talukdar, F. R., Ghosh, S. K., Laskar, R. S. & Mondal, R. Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India. PloS one 8, e60996, doi:10.1371/journal.pone.0060996 (2013).
6. Okkenhaug, K. Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev Immunol 31, 675-704, doi:10.1146/annurev-immunol-032712-095946 (2013).
7. Carpenter, C. L. et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem 265, 19704-19711 (1990).
8. Chen, J. et al . Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PloS one 7, e40817, doi:10.1371/journal.pone.0040817 (2012).
9. Li, Q. et al. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population. PloS one 8, e71968, doi:10.1371/journal.pone.0071968 (2013).
10. Xu, M. et al. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population. PloS one 8, e60080, doi:10.1371/journal.pone.0060080 (2013).
11. Hirashima, K. et al. Aberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma. Br J Cancer 106, 876-882, doi:10.1038/bjc.2012.36 (2012).
12. Shigaki, H. et al. PIK3CAmutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Clin Cancer Res 19, 2451-2459, doi:10.1158/1078-0432.CCR-12-3559 (2013).
13. Wang, L. E. et al. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol 138, 377-385, doi:10.1007/s00432-011-1103-0 (2012).
14. Heist, R. S.&Engelman, J.A. SnapShot: non-small cell lung cancer. Cancer Cell 21, 448 e442 doi:10.1016/j.ccr.2012.03.007 (2012).
15. Chappell, W. H. et al. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2, 135-164 (2011).
16. Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2, 489-501, doi:10.1038/nrc839 (2002).
17. Fingar, D. C., Salama, S., Tsou, C., Harlow, E. & Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16, 1472-1487, doi:10.1101/gad.995802 (2002).
18. Chen, Z. et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature 483, 613-617, doi:10.1038/nature10937 (2012).
19. Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570-575, doi:10.1038/nature11005 (2012).
20. Maeng, C. H. et al. High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations. PloS one 7, e41655, doi:10.1371/journal.pone.0041655 (2012).
21. Boone, J. et al . mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy? J Clin Pathol 61, 909-913, doi:10.1136/jcp.2008.055772 (2008).
22. Slattery, M. L. et al. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinogenesis 31, 1604-1611, doi:10.1093/carcin/bgq142 (2010).
23. Zhu, M. L. et al. Polymorphisms in mTORC1 genes modulate risk of esophageal squamous cell carcinoma in eastern Chinese populations. J Thorac Oncol 8, 788-795, doi:10.1097/JTO.0b013e31828916c6 (2013).
24. He, J. et al. Genetic variations of mTORC1 genes and risk of gastric cancer in an eastern chinese population. Mol Carcinogenesis 52 Suppl 1, 70-79, doi:10.1002/mc.22013 (2013).
25. Cao, Q. et al. A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk. PloS one 7, e50302, doi:10.1371/journal.pone.0050302 (2012).
26. Huang, L. et al . Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population. Leuk Lymphoma 53, 947-951, doi:10.3109/10428194.2011.628062 (2012).
27. Weiss, J. M., Goode, E. L., Ladiges, W. C. &Ulrich, C.M. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinogenesis 42, 127-141, doi:10.1002/mc.20067 (2005).
28. Feng, X. S. et al. Prevalence and age, gender and geographical area distribution of esophageal squamous cell carcinomas in North China from 1985 to 2006. Asian Pac J Cancer Prev 15, 1981-1987 (2014).
29. Holmes, R. S. & Vaughan, T. L. Epidemiology and pathogenesis of esophageal cancer. Seminars in radiation oncology 17, 2-9, doi:10.1016/j.semradonc.2006.09.003 (2007).
30. Prabhu, A., Obi, K. O. & Rubenstein, J. H. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol 109, 822-827, doi:10.1038/ajg.2014.71 (2014).
31. Lahmann, P. H. et al. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer 118, 1901-1909, doi:10.1002/cncr.26455 (2012).
32. Chow, W. H. et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90, 150-155 (1998).
33. Wang, X. et al. Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC public health 9, 223, doi:10.1186/1471-2458-9-223 (2009).
34. Zhu, M. L. et al. Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations. PloS one 7, e41500, doi:10.1371/journal.pone.0041500 (2012).
35. Jih, J. et al . Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med 65, 1-6 (2014).
36. He, J. et al. Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet 131, 1235-1244, doi:10.1007/s00439-012-1152-8 (2012).
37. Hahn, L.W., Ritchie, M. D. & Moore, J. H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376-382 (2003).
38. Zhu, J. et al. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis. PloS one 9, e97616, doi:10.1371/journal.pone.0097616 (2014).
39. He, Y. Q. et al. The association between the polymorphisms of TNF-alpha and non-Hodgkin lymphoma: a meta-analysis. Tumour Biol 35, 12509-12517, doi:10.1007/s13277-014-2569-6 (2014).